查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386418

靜脈疾病治療市場報告：2030 年趨勢、預測與競爭分析

Venous Diseases Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

靜脈疾病治療的趨勢與預測

預計到 2030 年，全球靜脈疾病治療市場將達到約 91 億美元，2024 年至 2030 年年複合成長率為 6.5%。該市場的主要促進因素是靜脈疾病盛行率的增加、人們對靜脈疾病的認知不斷提高以及醫療保健支出的增加。全球靜脈疾病治療市場包括硬化治療、射頻消融、雷射治療、門診靜脈曲張切除術、靜脈結紮/解剖、血管成形術或置入術、手術、壓迫療法、靜脈促效劑和未來性是有希望的。

靜脈疾病治療市場洞察

Lucintel 預測，由於靜脈曲張病例的增加和治療靜脈曲張的微創手術，靜脈曲張仍將是最大的部分。

在這個市場中，雷射治療預計將在預測期內呈現最高成長。這是由於對治療時間較短的微創手術的需求不斷增加，以及治療靜脈疾病的技術不斷發展。

由於美國口中靜脈曲張疾病的增加、人口高齡化的顯著成長以及診斷和治療技術的進步，北美可能仍然是最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和業務風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球靜脈疾病治療市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球靜脈疾病治療市場趨勢（2018-2023）與預測（2024-2030）
  • 按產品類型分類的全球靜脈疾病治療市場
    • 硬化劑注射
    • 消融裝置
    • 靜脈縫合產品
    • 靜脈支架
    • 藥品
    • 其他
  • 按疾病類型分類的全球靜脈疾病治療市場
    • 深層靜脈栓塞症
    • 慢性靜脈功能不全
    • 肺動脈栓塞
    • 血栓性淺靜脈炎
    • 靜脈曲張
    • 其他
  • 按治療類型分類的全球靜脈疾病治療市場
    • 硬化療法
    • 射頻消融術治療
    • 雷射治療
    • 切除術切除術
    • 靜脈結紮和剝離
    • 血管成形術或置入術
    • 外科手術
    • 壓迫療法
    • 其他
  • 按最終用途分類的全球靜脈疾病治療市場
    • 醫院
    • 診所
    • 門診手術中心
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球靜脈疾病治療市場（按地區）
  • 北美靜脈疾病治療市場
  • 歐洲靜脈疾病治療市場
  • 亞太靜脈疾病治療市場
  • 其他區域性靜脈疾病治療市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品類型分類的全球靜脈疾病治療市場成長機會
    • 按疾病類型分類的全球靜脈疾病治療市場成長機會
    • 全球靜脈疾病治療市場成長機會（依治療類型）
    • 全球靜脈疾病治療市場的成長機會（依最終用途）
    • 全球靜脈疾病治療市場按地區成長機會
  • 全球靜脈疾病治療市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球靜脈疾病治療市場的產能
    • 全球靜脈疾病治療市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • Abbott
  • Imricor
  • Medtronic
  • Stryker
  • Koninklijke Philips
  • Baylis Medical
  • Theraclion
  • Sonablate
  • Boston Scientific
  • Olympus
簡介目錄

Venous Diseases Treatment Trends and Forecast

The future of the global venous diseases treatment market looks promising with opportunities in the sclerotherapy, radiofrequency ablation therapy, laser treatment, ambulatory phlebectomy, vein ligation & stripping, angioplasty or stenting, surgeries, compression therapy, venoactive medication, and vena cava filter markets. The global venous diseases treatment market is expected to reach an estimated $9.1 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing incidences of venous diseases, growing awareness towards venous disorders, and rising healthcare expenditure.

A more than 150-page report is developed to help in your business decisions.

Venous Diseases Treatment by Segment

The study includes a forecast for the global venous diseases treatment by product type, disease type, treatment type, end use, and region.

Venous Diseases Treatment Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Sclerotherapy Injection
  • Ablation Devices
  • Venous Closure Products
  • Venous Stents
  • Medication
  • Others

Venous Diseases Treatment Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

  • Deep Vein Thrombosis
  • Chronic Venous Insufficiency
  • Pulmonary Embolism
  • Superficial Thrombophlebitis
  • Varicose Veins
  • Others

Venous Diseases Treatment Market by Treatment Type [Shipment Analysis by Value from 2018 to 2030]:

  • Sclerotherapy
  • Radiofrequency Ablation Therapy
  • Laser Treatment
  • Ambulatory Phlebectomy
  • Vein Ligation & Stripping
  • Angioplasty Or Stenting
  • Surgeries
  • Compression Therapy
  • Others

Venous Diseases Treatment Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

Venous Diseases Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Venous Diseases Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies venous diseases treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the venous diseases treatment companies profiled in this report include-

  • Abbott
  • Imricor
  • Medtronic
  • Stryker
  • Koninklijke Philips
  • Baylis Medical
  • Theraclion
  • Sonablate
  • Boston Scientific
  • Olympus

Venous Diseases Treatment Market Insights

Lucintel forecasts that varicose veins will remain the largest segment due to the increasing cases of varicose veins and minimally invasive procedures to treat varicose veins.

Within this market, laser treatment is expected to witness highest growth over the forecast period due to rising demand for minimal invasive procedure with less cure time and om-going technological development to treat venous diseases.

North America will remain the largest region due to growing number of varicose veins diseases among the US population, significantly growing aging population, and technological advancement of diagnosis and treatment in the region.

Features of the Global Venous Diseases Treatment Market

Market Size Estimates: Venous diseases treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Venous diseases treatment market size by various segments, such as by product type, disease type, treatment type, end use, and region in terms of ($B).

Regional Analysis: Venous diseases treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, disease types, treatment types, end uses, and regions for the venous diseases treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the venous diseases treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the venous diseases treatment market size?

Answer: The global venous diseases treatment market is expected to reach an estimated $9.1 billion by 2030.

Q.2 What is the growth forecast for venous diseases treatment market?

Answer: The global venous diseases treatment market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the venous diseases treatment market?

Answer: The major drivers for this market are increasing incidences of venous diseases, growing awareness towards venous disorders, and rising healthcare expenditure.

Q4. What are the major segments for venous diseases treatment market?

Answer: The future of the venous diseases treatment market looks promising with opportunities in the sclerotherapy, radiofrequency ablation therapy, laser treatment, ambulatory phlebectomy, vein ligation & stripping, angioplasty or stenting, surgeries, compression therapy, venoactive medication, and vena cava filter markets.

Q5. Who are the key venous diseases treatment market companies?

Answer: Some of the key venous diseases treatment companies are as follows:

  • Abbott
  • Imricor
  • Medtronic
  • Stryker
  • Koninklijke Philips
  • Baylis Medical
  • Theraclion
  • Sonablate
  • Boston Scientific
  • Olympus

Q6. Which venous diseases treatment market segment will be the largest in future?

Answer: Lucintel forecasts that varicose veins will remain the largest segment due to the increasing cases of varicose veins and minimally invasive procedures to treat varicose veins.

Q7. In venous diseases treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to growing number of varicose veins diseases among the US population, significantly growing aging population, and technological advancement of diagnosis and treatment in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the venous diseases treatment market by product type (sclerotherapy injection, ablation devices, venous closure products, venous stents, medication, and others), disease type (deep vein thrombosis, chronic venous insufficiency, pulmonary embolism, superficial thrombophlebitis, varicose veins, and others), treatment type (sclerotherapy, radiofrequency ablation therapy, laser treatment, ambulatory phlebectomy, vein ligation & stripping, angioplasty or stenting, surgeries, compression therapy, and others), end use (hospitals, clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Venous Diseases Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Venous Diseases Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Venous Diseases Treatment Market by Product Type
    • 3.3.1: Sclerotherapy Injection
    • 3.3.2: Ablation Devices
    • 3.3.3: Venous Closure Products
    • 3.3.4: Venous Stents
    • 3.3.5: Medication
    • 3.3.6: Others
  • 3.4: Global Venous Diseases Treatment Market by Disease Type
    • 3.4.1: Deep Vein Thrombosis
    • 3.4.2: Chronic Venous Insufficiency
    • 3.4.3: Pulmonary Embolism
    • 3.4.4: Superficial Thrombophlebitis
    • 3.4.5: Varicose Veins
    • 3.4.6: Others
  • 3.5: Global Venous Diseases Treatment Market by Treatment Type
    • 3.5.1: Sclerotherapy
    • 3.5.2: Radiofrequency ablation therapy
    • 3.5.3: Laser Treatment
    • 3.5.4: Ambulatory Phlebectomy
    • 3.5.5: Vein Ligation & stripping
    • 3.5.6: Angioplasty or Stenting
    • 3.5.7: Surgeries
    • 3.5.8: Compression Therapy
    • 3.5.9: Others
  • 3.6: Global Venous Diseases Treatment Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Clinics
    • 3.6.3: Ambulatory Surgical Centers
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Venous Diseases Treatment Market by Region
  • 4.2: North American Venous Diseases Treatment Market
    • 4.2.1: North American Venous Diseases Treatment Market by Disease Type: Deep Vein Thrombosis, Chronic Venous Insufficiency, Pulmonary Embolism, Superficial Thrombophlebitis, Varicose Veins, and Others
    • 4.2.2: North American Venous Diseases Treatment Market by Treatment Type: Sclerotherapy, Radiofrequency ablation therapy, Laser Treatment, Ambulatory Phlebectomy, Vein Ligation & stripping, Angioplasty or Stenting, Surgeries, Compression Therapy, and Others
  • 4.3: European Venous Diseases Treatment Market
    • 4.3.1: European Venous Diseases Treatment Market by Disease Type: Deep Vein Thrombosis, Chronic Venous Insufficiency, Pulmonary Embolism, Superficial Thrombophlebitis, Varicose Veins, and Others
    • 4.3.2: European Venous Diseases Treatment Market by Treatment Type: Sclerotherapy, Radiofrequency ablation therapy, Laser Treatment, Ambulatory Phlebectomy, Vein Ligation & stripping, Angioplasty or Stenting, Surgeries, Compression Therapy, and Others
  • 4.4: APAC Venous Diseases Treatment Market
    • 4.4.1: APAC Venous Diseases Treatment Market by Disease Type: Deep Vein Thrombosis, Chronic Venous Insufficiency, Pulmonary Embolism, Superficial Thrombophlebitis, Varicose Veins, and Others
    • 4.4.2: APAC Venous Diseases Treatment Market by Treatment Type: Sclerotherapy, Radiofrequency ablation therapy, Laser Treatment, Ambulatory Phlebectomy, Vein Ligation & stripping, Angioplasty or Stenting, Surgeries, Compression Therapy, and Others
  • 4.5: ROW Venous Diseases Treatment Market
    • 4.5.1: ROW Venous Diseases Treatment Market by Disease Type: Deep Vein Thrombosis, Chronic Venous Insufficiency, Pulmonary Embolism, Superficial Thrombophlebitis, Varicose Veins, and Others
    • 4.5.2: ROW Venous Diseases Treatment Market by Treatment Type: Sclerotherapy, Radiofrequency ablation therapy, Laser Treatment, Ambulatory Phlebectomy, Vein Ligation & stripping, Angioplasty or Stenting, Surgeries, Compression Therapy, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Venous Diseases Treatment Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Venous Diseases Treatment Market by Disease Type
    • 6.1.3: Growth Opportunities for the Global Venous Diseases Treatment Market by Treatment Type
    • 6.1.4: Growth Opportunities for the Global Venous Diseases Treatment Market by End Use
    • 6.1.5: Growth Opportunities for the Global Venous Diseases Treatment Market by Region
  • 6.2: Emerging Trends in the Global Venous Diseases Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Venous Diseases Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Venous Diseases Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott
  • 7.2: Imricor
  • 7.3: Medtronic
  • 7.4: Stryker
  • 7.5: Koninklijke Philips
  • 7.6: Baylis Medical
  • 7.7: Theraclion
  • 7.8: Sonablate
  • 7.9: Boston Scientific
  • 7.10: Olympus